Wednesday 29 July 2020

Reuters Health Report: EU buys limited supply of COVID drug remdesivir, seeks more

Reuters.com Newsletter

EU buys limited supply of COVID drug remdesivir, seeks more

The European Union's executive said on Wednesday it had agreed to buy a limited supply of the COVID-19 drug remdesivir from U.S. drugmaker Gilead to address the short-term needs of European patients, and hoped to be able to order more later.

What you need to know about the coronavirus right now

Here's what you need to know about the coronavirus right now:

Trump on Fauci's high approval ratings: 'Nobody likes me'

President Donald Trump groused on Tuesday about medical expert Anthony Fauci's high approval ratings and joked that "nobody likes me" as he struggles to improve his standing with voters for his handling of the coronavirus pandemic.

Vietnam says every city, province now at risk of virus infection

Vietnam, virus-free for months, was bracing for another wave of COVID-19 infections on Wednesday after state media reported new cases in Hanoi, Ho Chi Minh City and the Central Highlands linked to a recent outbreak in the central city of Danang.

South Korea's Green Cross seeks phase two trials of COVID-19 plasma drug

South Korea's Green Cross Corp has sought regulatory approval for Phase II trials of an experimental COVID-19 blood plasma treatment drug, the company said on Wednesday, sending its shares up nearly 10%.

U.S. records 10,000 coronavirus deaths in 11 days as fatalities approach 150,000

U.S. deaths from the novel coronavirus were approaching 150,000 on Wednesday, the highest level in the world and rising by 10,000 in 11 days, according to a Reuters tally.

UK's Recovery trial to continue testing Roche drug for COVID-19

A major UK trial looking at whether some existing drugs may be used to treat COVID-19 is to continue testing Roche's arthritis drug Actemra, also known as tocilizumab, despite separate trial results on Wednesday showing it had no benefit.

Roche bid to retool arthritis drug for COVID-19 fails

Roche's attempt to retool its rheumatoid arthritis drug Actemra/RoActemra to treat patients hospitalised with severe COVID-19-related pneumonia has failed in a late-stage trial, the Swiss company said on Wednesday.

Takeda-led COVID-19 plasma treatment unlikely to meet July goal of trial start

A group led by Takeda Pharmaceutical Co have completed test supplies of a blood plasma treatment for COVID-19, but pending regulator approval will likely prevent clinical trials from meeting a July start date.

Philippines confirms 1,874 new coronavirus cases, 16 deaths

The Philippine health ministry on Wednesday reported 1,874 new coronavirus infections and 16 additional COVID-19 deaths.

Hong Kong reports 118 new coronavirus cases as local transmissions stay high

Hong Kong reported 118 new coronavirus cases on Wednesday, including 113 that were locally transmitted, as strict new measures including a restriction of gatherings to two people and a ban on restaurant dining, took effect.

Related Videos

U.S. records 1,000 covid deaths for fourth day

Record rise in coronavirus cases around the globe

Introducing the all-new
Reuters News app

The new Reuters News app is here, redesigned from the ground up to fit your busy life.

Get it now on iOS